Latest news
Loading news…
AbCheck provides an antibody discovery platform that discovers and optimizes human therapeutic antibodies.
AbCheck was acquired by Ampersand Biomedicines in 2024 for $6M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Plzen, Plzensky kraj, Czech Republic
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to AbCheck
Loading news…
FAQs about AbCheck
People who checked this page also checked these
Browse the full Acquirezy directory.